Clinical Trial Update: Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI [Phase 4]

View source ↗

Summary

Phase 4 trial comparing low maintenance dose ticagrelor versus clopidogrel in patients with type 2 diabetes undergoing PCI; results completed and posted in 2021…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: University of Florida | Conditions: Diabetes Mellitus, Type 2, Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2021-02-05